Clinical Trial Results:
            Open-label, randomized, controlled Phase I/II study of cilengitide to evaluate the safety and efficacy of the combination of different regimens of cilengitide added to cisplatin, 5-FU, and cetuximab in subjects with recurrent/metastatic squamous cell cancer of the head and neck.
    
| 
                 Summary 
         | 
        |
    EudraCT number  | 
        2008-000615-15 | 
    Trial protocol  | 
        BE AT DE FR HU IT | 
    Global completion date  | 
        
                                    20 Jun 2013
                             
         | 
    
| 
                 Paediatric regulatory details 
         | 
        |
    Is the trial part of an agreed EMA paediatric investigation plan?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
    Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?  | 
        
                                        No
                                 
         | 
    
| 
                 Results information 
         | 
        |
    Results version number  | 
        v1(current) | 
    This version publication date  | 
        
                                    24 Feb 2017
                             
         | 
    
    First version publication date  | 
        
                                    24 Feb 2017
                             
         | 
    
    Other versions  | 
        |
    Summary report(s)  | 
                                2008-000615-15_CT.gov results | 
    
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.